ArticleInternational journal of cardiology. Heart & vasculature2022
Very-high-power short-duration ablation for treatment of premature ventricular contractions - The FAST-AND-FURIOUS PVC study.
Article in International journal of cardiology. Heart & vasculature, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed, 13 citations in OpenAlex.
- Esophageal heating characteristics of very high-power short duration radiofrequency ablation in a myocardial phantom model.Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing · 2026Article
- Lesion formation and impedance dependence of v-HPSD ablation (QDOT-MICRO™) versus conventional power-control (SmartTouch™ SF): a head-to-head comparison in an ex vivo porcine model.BMC cardiovascular disorders · 2026Article
- Very High-Power Short-Duration Ablation for Premature Ventricular Complexes From Sites With Suboptimal Catheter Stability.Journal of cardiovascular electrophysiology · 2026Article
- Ablation Methods and Catheter Settings for Ventricular Tachycardia Ablation: A Bench to Bedside Review: Part 1.Arrhythmia & electrophysiology review · 2026Review
- Predictive value of surface electrocardiogram in localizing right ventricular outflow tract premature beats: a study combining intracardiac echocardiography and electroanatomical mapping under all-zero fluoroscopy ablation.Frontiers in physiology · 2025Article
- Recent highlights from theInternational journal of cardiology. Heart & vasculature · 2024Article
- Transient coronary artery dissection analysed with optical coherence tomography during radiofrequency catheter ablation.European heart journal. Case reports · 2024Article
- [Ventricular tachycardia-without structural heart disease: History].Herzschrittmachertherapie & Elektrophysiologie · 2024Review
- Optimal catheter ablation procedure for premature ventricular contraction originating from the free wall of tricuspid annulus.Clinical cardiology · 2024Article
- Is catheter-tissue contact force value important for ablation of ventricular arrhythmias originating from the left ventricular papillary muscles?Frontiers in cardiovascular medicine · 2023Article
- Very high-power short-duration ablation for treatment of premature ventricular contractions: Truth or Dare?International journal of cardiology. Heart & vasculature · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors at 4 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: We sought to assess the efficacy, safety and short-term clinical outcome of very high-power short-duration (vHP-SD) radiofrequency (RF) catheter ablation for the treatment of idiopathic PVCs originating from the cardiac outflow tract (OT). Background: Power-controlled RF ablation is a widely used technique for the treatment of premature ventricular contractions (PVCs). A novel ablation catheter offers three microelectrodes and six thermocouples at its tip and provides temperature-controlled vHP-SD (90 Watts/4 s,) with the opportunity to switch to moderate-power mode. Methods: In this pilot study, twenty-four consecutive, prospectively enrolled patients underwent PVC ablation utilizing the vHP-SD ablation (study group) and were compared with 24 consecutive patients previously treated with power-controlled ablation (control group). Each group included 12 patients with PVCs originating from the right ventricular OT (RVOT) and 12 patients with PVCs originating from the left ventricular OT (LVOT). The acute endpoint was PVC elimination and was achieved in all patients. Results: In 16/24 (67%) patients (study group) it was achieved by using vHP-SD only. The median RF delivery time was 52 (interquartile range [IQR] 16, 156) seconds (study group) and 350 (IQR 240, 442) seconds (control group, p < 0.0001). No difference was observed regarding procedure duration (p = 0.489) as well as 6-months follow-up (p = 0.712). One (4%, study group) and 2 (8%, control group) severe adverse events occured (p = 0.551). Conclusion: In this study
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.